Page last updated: 2024-08-17

isatin and Cancer of Ovary

isatin has been researched along with Cancer of Ovary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Anand, A; Chowdhary, S; Kaur, S; Kumar, V; Raza, A; Sharma, AK1
Abdalla, AN; Al-Salem, HS; Albalawi, FS; Alkahtani, HM; Alqathama, A; Arifuzzaman, M; Issa, IS; Rahman, AFMM1

Other Studies

2 other study(ies) available for isatin and Cancer of Ovary

ArticleYear
Isatin-indoloquinoxaline click adducts with a potential to overcome platinum-based drug-resistance in ovarian cancer.
    Bioorganic chemistry, 2024, Volume: 142

    Topics: Antineoplastic Agents; Cell Line, Tumor; DNA; Female; Humans; Intercalating Agents; Isatin; Ovarian Neoplasms; Structure-Activity Relationship

2024
A Series of Isatin-Hydrazones with Cytotoxic Activity and CDK2 Kinase Inhibitory Activity: A Potential Type II ATP Competitive Inhibitor.
    Molecules (Basel, Switzerland), 2020, Sep-25, Volume: 25, Issue:19

    Topics: Breast Neoplasms; Cyclin-Dependent Kinase 2; Cytotoxins; Female; Humans; Hydrazones; Isatin; MCF-7 Cells; Molecular Docking Simulation; Neoplasm Proteins; Ovarian Neoplasms; Protein Kinase Inhibitors

2020
chemdatabank.com